rdf:type |
|
lifeskim:mentions |
umls-concept:C0006141,
umls-concept:C0006142,
umls-concept:C0019929,
umls-concept:C0030705,
umls-concept:C0078988,
umls-concept:C0087111,
umls-concept:C0205160,
umls-concept:C0242957,
umls-concept:C0332293,
umls-concept:C0449438,
umls-concept:C0449560,
umls-concept:C0746922,
umls-concept:C0920467,
umls-concept:C1521991,
umls-concept:C1706163,
umls-concept:C2347858,
umls-concept:C2697524,
umls-concept:C2700445
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-4-6
|
pubmed:abstractText |
Our study investigates whether an approximation of breast cancer molecular subtypes using the hormone receptors and HER-2 status prognosticates for disease control after breast conservation therapy (BCT) in node-negative Asian breast cancer patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0304-4602
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
90-7
|
pubmed:meshHeading |
pubmed-meshheading:21468463-Adult,
pubmed-meshheading:21468463-Aged,
pubmed-meshheading:21468463-Aged, 80 and over,
pubmed-meshheading:21468463-Breast Neoplasms,
pubmed-meshheading:21468463-Female,
pubmed-meshheading:21468463-Humans,
pubmed-meshheading:21468463-Mastectomy, Segmental,
pubmed-meshheading:21468463-Middle Aged,
pubmed-meshheading:21468463-Multivariate Analysis,
pubmed-meshheading:21468463-Neoplasm Recurrence, Local,
pubmed-meshheading:21468463-Prognosis,
pubmed-meshheading:21468463-Radiotherapy, Adjuvant,
pubmed-meshheading:21468463-Receptor, erbB-2,
pubmed-meshheading:21468463-Receptors, Estrogen,
pubmed-meshheading:21468463-Receptors, Progesterone,
pubmed-meshheading:21468463-Retrospective Studies,
pubmed-meshheading:21468463-Risk Assessment,
pubmed-meshheading:21468463-Survival Analysis,
pubmed-meshheading:21468463-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy.
|
pubmed:affiliation |
Department of Radiation Oncology, National Cancer Centre Singapore, Singapore. fuhyong@yahoo.com
|
pubmed:publicationType |
Journal Article
|